XML 66 R54.htm IDEA: XBRL DOCUMENT v3.25.3
Equity - Changes in Total Equity (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Increase (Decrease) in Stockholders' Equity                
Balance at beginning of period     $ 3,823       $ 3,823  
Net income attributable to Ingredion $ 171     $ 188     564 $ 552
Net income (loss) attributable to non-controlling interests 1     1     5 5
Other comprehensive (loss)             136 56
Balance at end of period 4,259           4,259  
Increase (Decrease) in Temporary Equity                
Share-based payments subject to redemption, beginning balance 51 $ 42 60 50 $ 43 $ 55 60 55
Share-based compensation, net of issuance 7 9 (18) 4 7 (12) (2) (1)
Share-based payments subject to redemption, ending balance 58 51 42 54 50 43 58 54
Redeemable non-controlling interests, beginning balance 7 8 7 7 42 43 7 43
Net income attributable to non-controlling interests       (1) (1)     (2)
Fair market value adjustment to non-controlling interests         6     6
Purchases of non-controlling interests         (40)     (40)
Other comprehensive income (loss)   (1) 1 1   (1)    
Redeemable non-controlling interests, ending balance $ 7 $ 7 $ 8 $ 7 $ 7 $ 42 7 7
Dividends declared (in dollars per share) $ 0.82 $ 0.80 $ 0.80 $ 0.80 $ 0.78 $ 0.78    
Common Stock                
Increase (Decrease) in Stockholders' Equity                
Balance at beginning of period $ 1 $ 1 $ 1 $ 1 $ 1 $ 1 1 1
Balance at end of period 1 1 1 1 1 1 1 1
Additional Paid-In Capital                
Increase (Decrease) in Stockholders' Equity                
Balance at beginning of period 1,160 1,158 1,152 1,141 1,146 1,146 1,152 1,146
Share-based compensation, net of issuance (4) 2 6 4 1   4 5
Fair market value adjustment to non-controlling interests         (6)     (6)
Balance at end of period 1,156 1,160 1,158 1,145 1,141 1,146 1,156 1,145
Treasury Stock                
Increase (Decrease) in Stockholders' Equity                
Balance at beginning of period (1,391) (1,393) (1,355) (1,233) (1,179) (1,207) (1,355) (1,207)
Repurchases of common stock, net (79)   (55) (21) (65) (1) (134) (87)
Share-based compensation, net of issuance 4 2 17 9 11 29 23 49
Balance at end of period (1,466) (1,391) (1,393) (1,245) (1,233) (1,179) (1,466) (1,245)
Accumulated Other Comprehensive Loss                
Increase (Decrease) in Stockholders' Equity                
Balance at beginning of period (953) (1,025) (1,086) (1,118) (1,062) (1,056) (1,086) (1,056)
Other comprehensive (loss) 3 72 61 118 (56) (6) 136 56
Balance at end of period (950) (953) (1,025) (1,000) (1,118) (1,062) (950) (1,000)
Retained Earnings                
Increase (Decrease) in Stockholders' Equity                
Balance at beginning of period 5,380 5,236 5,092 4,914 4,818 4,654 5,092 4,654
Net income attributable to Ingredion 171 196 197 188 148 216 564 552
Dividends declared (54) (52) (53) (53) (52) (52) (159) (157)
Balance at end of period 5,497 5,380 5,236 5,049 4,914 4,818 5,497 5,049
Non- Redeemable Non- Controlling Interests                
Increase (Decrease) in Stockholders' Equity                
Balance at beginning of period 21 21 19 17 16 14 19 14
Net income (loss) attributable to non-controlling interests 1 2 2 2 3 2 5 7
Dividends declared (1) (2)   (1) (2)   (3) (3)
Other comprehensive (loss)       1       1
Balance at end of period $ 21 $ 21 $ 21 $ 19 $ 17 $ 16 $ 21 $ 19